Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass

Clinical trial NCT05057819 · COMPLETED

Trial details

NCT number: NCT05057819
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dumping Syndrome Hypoglycemia, Reactive

Start date: 2021-12-01
Primary completion: 2022-08-11
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.